CoChat

Breast cancer colonization by Fusobacterium nucleatum accelerates tumor growth and metastatic progression

Open access

The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.

Abstract

Fusobacterium nucleatum is an oral anaerobe recently found to be prevalent in human colorectal cancer (CRC) where it is associated with poor treatment outcome. In mice, hematogenous F. nucleatum can colonize CRC tissue using its lectin Fap2, which attaches to tumor-displayed Gal-GalNAc. Here, we show that Gal-GalNAc levels increase as human breast cancer progresses, and that occurrence of F. nucleatum gDNA in breast cancer samples correlates with high Gal-GalNAc levels. We demonstrate Fap2-dependent binding of the bacterium to breast cancer samples, which is inhibited by GalNAc. Intravascularly inoculated Fap2-expressing F. nucleatum ATCC 23726 specifically colonize mice mammary tumors, whereas Fap2-deficient bacteria are impaired in tumor colonization. Inoculation with F. nucleatum suppresses accumulation of tumor infiltrating T cells and promotes tumor growth and metastatic progression, the latter two of which can be counteracted by antibiotic treatment. Thus, targeting F. nucleatum or Fap2 might be beneficial during treatment of breast cancer.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-020-16967-2

Cites

55 of 55 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Gal-GalNAc is overdisplayed in breast cancer. a Representative images of human breast cancer and matched adjacent non-tumor (normal adj.) tissue using tissue microarray (HBre-Duc060CS-01) stained with FITC-labeled Gal-GalNAc-specific PNA lectin (green) and Hoechst dye (blue). Right panel: quantitative analysis of PNA binding (sum of fluorescence intensity) to each matching tumor and normal adjacent tissue cores. Each paired symbols represents one patient. Red symbols mark the five paired samples (out of 30) in which Gal-GalNAc level in the normal tissue was higher than that in the adjacent-tumor one. ***p = 0.0003, one-tailed, Wilcoxon matched-paired signed rank test, n = 30. b Representative images of human breast cancer hyperplasia, atypical hyperplasia, and normal tissue using tissue microarray (BR1003a) stained with FITC-labeled Gal-GalNAc-specific PNA lectin (green) and Hoechst dye (blue) (left panel). Right panel: quantitative analysis of PNA binding (sum of fluorescence intensity) to each tissue core. Each symbol represents one patient. **p = 0.0035 (normal–atypical hyperplasia), **p = 0.002 (hyperplasia–atypical hyperplasia), *p = 0.0415, n.s.: not significant, two-tailed Kruskal–Wallis test, normal n = 6, hyperplasia n = 14, atypical hyperplasia n = 6, malignant n = 20 (IDC + ILC, IDC: invasive ductal carcinoma, ILC: invasive lobular carcinoma). c Quantitative analysis of PNA binding (sum of fluorescence intensity) to types of human breast cancer, benign and normal adjacent (none matched) tissue using tissue microarray (BR1006) stained with FITC-labeled PNA. Each symbol represents one patient. ***p = 0.0004, ****p < 0.0001 between all the breast cancers and normal adj. and benign correspondingly, Holm-corrected Mann–Whitney test. n = 6 (normal adj.), n = 7 (benign), n = 36 (malignant). d–g Human breast cancer stained with FITC-labeled PNA (green), Cy5-anti-Cytokeratin-7 for glandular epithelia (yellow), TRITC-von willebrand factor for endothelial cells (red), and Hoechst dye (blue). High Gal-GalNAc levels can be detected in mucin regions in mucinous breast carcinoma (d), and in necrotic regions (e), and in duct and in duct lumen (e, f, g) of ductal breast cancer as indicated. Scale bar, 100 µm in (a, b), 50 µm in (d–g). Results presented in (d) and in (e–g) represent 2 and 3 reproducible independent experiments, respectively. Source data are provided as a Source data file.
Fig. 1 Gal-GalNAc is overdisplayed in breast cancer. a Representative images of human breast cancer and matched adjacent non-tumor (normal adj.) tissue using tissue microarray (HBre-Duc060CS-01) stained with FITC-labeled Gal-GalNAc-specific PNA lectin (green) and Hoechst dye (blue). Right panel: quantitative analysis of PNA binding (sum of fluorescence intensity) to each matching tumor and normal adjacent tissue cores. Each paired symbols represents one patient. Red symbols mark the five paired samples (out of 30) in which Gal-GalNAc level in the normal tissue was higher than that in the adjacent-tumor one. ***p = 0.0003, one-tailed, Wilcoxon matched-paired signed rank test, n = 30. b Representative images of human breast cancer hyperplasia, atypical hyperplasia, and normal tissue using tissue microarray (BR1003a) stained with FITC-labeled Gal-GalNAc-specific PNA lectin (green) and Hoechst dye (blue) (left panel). Right panel: quantitative analysis of PNA binding (sum of fluorescence intensity) to each tissue core. Each symbol represents one patient. **p = 0.0035 (normal–atypical hyperplasia), **p = 0.002 (hyperplasia–atypical hyperplasia), *p = 0.0415, n.s.: not significant, two-tailed Kruskal–Wallis test, normal n = 6, hyperplasia n = 14, atypical hyperplasia n = 6, malignant n = 20 (IDC + ILC, IDC: invasive ductal carcinoma, ILC: invasive lobular carcinoma). c Quantitative analysis of PNA binding (sum of fluorescence intensity) to types of human breast cancer, benign and normal adjacent (none matched) tissue using tissue microarray (BR1006) stained with FITC-labeled PNA. Each symbol represents one patient. ***p = 0.0004, ****p < 0.0001 between all the breast cancers and normal adj. and benign correspondingly, Holm-corrected Mann–Whitney test. n = 6 (normal adj.), n = 7 (benign), n = 36 (malignant). d–g Human breast cancer stained with FITC-labeled PNA (green), Cy5-anti-Cytokeratin-7 for glandular epithelia (yellow), TRITC-von willebrand factor for endothelial cells (red), and Hoechst dye (blue). High Gal-GalNAc levels can be detected in mucin regions in mucinous breast carcinoma (d), and in necrotic regions (e), and in duct and in duct lumen (e, f, g) of ductal breast cancer as indicated. Scale bar, 100 µm in (a, b), 50 µm in (d–g). Results presented in (d) and in (e–g) represent 2 and 3 reproducible independent experiments, respectively. Source data are provided as a Source data file.CC BY · PubMed Central
Fig. 2 F. nucleatum gDNA is overabundant in breast cancer displaying high Gal-GalNAc levels. a The prevalence of F. nucleatum in breast tumors (n = 50) is shown and compared with DNA extraction controls (control, n = 50), PCR controls (NTC, n = 50), and colon tumors (n = 21). b Normalized read count (reads normalized to the average number of reads across different libraries) of F. nucleatum in each of the above samples (each dot represents the read counts of F. nucleatum in the sample) is shown (control n = 50, NTC n = 50, breast cancer n = 50, colon cancer n = 21). c Gal-GalNAc levels (measured using FITC-labeled PNA) in F. nucleatum-containing breast cancer samples (Fusobacteria+, n = 7) and in the samples in which F. nucleatum gDNA was not detected (ND, n = 6). *p = 0.0221, two-tailed Mann–Whitney test. Source data are provided as a Source data file.
Fig. 2 F. nucleatum gDNA is overabundant in breast cancer displaying high Gal-GalNAc levels. a The prevalence of F. nucleatum in breast tumors (n = 50) is shown and compared with DNA extraction controls (control, n = 50), PCR controls (NTC, n = 50), and colon tumors (n = 21). b Normalized read count (reads normalized to the average number of reads across different libraries) of F. nucleatum in each of the above samples (each dot represents the read counts of F. nucleatum in the sample) is shown (control n = 50, NTC n = 50, breast cancer n = 50, colon cancer n = 21). c Gal-GalNAc levels (measured using FITC-labeled PNA) in F. nucleatum-containing breast cancer samples (Fusobacteria+, n = 7) and in the samples in which F. nucleatum gDNA was not detected (ND, n = 6). *p = 0.0221, two-tailed Mann–Whitney test. Source data are provided as a Source data file.CC BY · PubMed Central
Fig. 3 Attachment of F. nucleatum ATCC 23726 to breast cancer is Fap2-mediated and Gal-GalNAc dependent. a Representative images (left panels, scale bar 20 µm) and quantitative analysis (Fn/mm2) (right panel) of binding of Cy3-labeled (white) WT F. nucleatum ATCC 23726 (726) and of its Cy5-labeled (red) Fap2-inactivated isogenic mutant K50, to Hoechst-stained (blue) human breast cancer TMAs (HBre-Duc060CS-01 and BR1006). Results in the right panel are classified by tissue type (normal n = 35, benign n = 7, malignant n = 64) and bacterial strain (K50, 726). Each core is measured twice, once for each of the strains in the appropriate tissue type (as demonstrated in the pictures). When an individual contributed a single core to the experiment, the two observations are shown as circles (●); when she contributed two cores, these were to the normal type and the malignant type, and the four observations are depicted as plus signs (+). The six classes were compared against each other in pairs: the exact two-tailed Wilcoxon test was used for pairs that were from the same core, the exact two-tailed Mann–Whitney test for independent samples. Where the same hypothesis was tested on more than one pair, and the individual pairs were mutually independent, the corresponding p-values were combined by Fisher’s method. Wherever the pairs were not independent, the multiple comparisons were adjusted for using the Holm modification of the Bonferroni correction. ****p < 0.0001, ***p = 0.00079, n.s.: not significant. b Flow cytometry analysis of attachment of FITC-labeled PNA and of FITC-labeled F. nucleatum ATCC 23726 (726) and its Fap2-inactivated isogenic mutants K50 and D22 to breast cancer cell lines 4T1, AT3 (mouse cell lines), MCF-7 (human cell line) (n = 5 each), and mouse melanoma cell line B16 used as a control (n = 3), in the absence or presence of increasing amounts of soluble GalNAc. Bars indicate mean ± SEM. Each symbol represents average of 10,000 cells examined in duplicate. Data shown are representative of two independent experiments. *p = 0.0313, one-tailed, Wilcoxon matched-paired signed rank test (726, 0 mM–726, 400 mM GalNAc). *p = 0.0119 (all others), Holm-corrected one-tailed Mann–Whitney test. Source data are provided as a Source data file.
Fig. 3 Attachment of F. nucleatum ATCC 23726 to breast cancer is Fap2-mediated and Gal-GalNAc dependent. a Representative images (left panels, scale bar 20 µm) and quantitative analysis (Fn/mm2) (right panel) of binding of Cy3-labeled (white) WT F. nucleatum ATCC 23726 (726) and of its Cy5-labeled (red) Fap2-inactivated isogenic mutant K50, to Hoechst-stained (blue) human breast cancer TMAs (HBre-Duc060CS-01 and BR1006). Results in the right panel are classified by tissue type (normal n = 35, benign n = 7, malignant n = 64) and bacterial strain (K50, 726). Each core is measured twice, once for each of the strains in the appropriate tissue type (as demonstrated in the pictures). When an individual contributed a single core to the experiment, the two observations are shown as circles (●); when she contributed two cores, these were to the normal type and the malignant type, and the four observations are depicted as plus signs (+). The six classes were compared against each other in pairs: the exact two-tailed Wilcoxon test was used for pairs that were from the same core, the exact two-tailed Mann–Whitney test for independent samples. Where the same hypothesis was tested on more than one pair, and the individual pairs were mutually independent, the corresponding p-values were combined by Fisher’s method. Wherever the pairs were not independent, the multiple comparisons were adjusted for using the Holm modification of the Bonferroni correction. ****p < 0.0001, ***p = 0.00079, n.s.: not significant. b Flow cytometry analysis of attachment of FITC-labeled PNA and of FITC-labeled F. nucleatum ATCC 23726 (726) and its Fap2-inactivated isogenic mutants K50 and D22 to breast cancer cell lines 4T1, AT3 (mouse cell lines), MCF-7 (human cell line) (n = 5 each), and mouse melanoma cell line B16 used as a control (n = 3), in the absence or presence of increasing amounts of soluble GalNAc. Bars indicate mean ± SEM. Each symbol represents average of 10,000 cells examined in duplicate. Data shown are representative of two independent experiments. *p = 0.0313, one-tailed, Wilcoxon matched-paired signed rank test (726, 0 mM–726, 400 mM GalNAc). *p = 0.0119 (all others), Holm-corrected one-tailed Mann–Whitney test. Source data are provided as a Source data file.CC BY · PubMed Central
Fig. 4 F. nucleatum colonizes mammary cancer in a Fap2-mediated mechanism. a Orthotropic 4T1 BALB/c mouse mammary cancer model. When reaching 500 mm3 size, 5 × 107 F. nucleatum ATCC 23726 were IV injected. Twenty-four hours post inoculation, breast cancer and normal tissue from an adjacent mammary were harvested. b Representative images and sum of fluorescence intensity of binding of FITC-labeled PNA (green) to tumor and normal tissue stained with Hoechst dye (blue). Each paired symbols represents one mouse (n = 7), **p = 0.0078, one-tailed, Wilcoxon matched-paired signed rank test. c Relative F. nucleatum gDNA abundance (2−ΔCt) in breast tissue from tumor-free mice (No tumor, n = 3), and in tumor and matching normal tissue of 4T1 tumor-bearing mice (n = 5) all inoculated with F. nucleatum ATCC 23726. *p = 0.0358 Holm-corrected one-tailed Mann–Whitney test. *p = 0.0313, one-tailed, Wilcoxon matched-paired signed rank test (for paired normal adjacent-tumor samples). d Orthotropic AT3 C57BL/6 mouse mammary cancer model. When reaching 500 mm3, mice were inoculated with 5 × 107 F. nucleatum ATCC 23726 (726; blue), 5 × 107 Fap2 mutant K50 (MUT K50; red) or with 5 × 107 P. gingivalis (Pg; black). Twenty-four hours later, normal mammary and breast cancer tissue were harvested from each mice and bacteria quantified. e Bacterial abundance (CFU/g tissue), and relative bacterial gDNA abundance (2−ΔCt) in tumor and normal tissue of AT3 tumor-bearing mice inoculated with P. gingivalis (Pg, n = 9), K50 (n = 12), or F. nucleatum ATCC 23726 (726, n = 12). Each symbol represents one mouse. *p = 0.0156 one-tailed, Wilcoxon matched-paired signed rank test. ***p = 0.0006, **p = 0.001598. Holm-corrected one-tailed Mann–Whitney test (left panel). ****p < 0.0001. One-tailed, Wilcoxon matched-paired signed rank test. ****p < 0.0001 (726 – Pg). One-tailed Mann–Whitney test, Holm’s modification of Bonferroni correction (right panel). f Representative multiphoton microscopy images of tumor and of normal adjacent mammary samples harvested 24 h post-IV injection of AT3 cancer bearing mice with 5 × 107 FITC-labeled F. nucleatum ATCC 23726 or with PBS vehicle. Scale bar, 50 µm in (b), 10 µm in (f). Data shown are representative of three independent reproducible experiments. Source data are provided as a Source data file.
Fig. 4 F. nucleatum colonizes mammary cancer in a Fap2-mediated mechanism. a Orthotropic 4T1 BALB/c mouse mammary cancer model. When reaching 500 mm3 size, 5 × 107 F. nucleatum ATCC 23726 were IV injected. Twenty-four hours post inoculation, breast cancer and normal tissue from an adjacent mammary were harvested. b Representative images and sum of fluorescence intensity of binding of FITC-labeled PNA (green) to tumor and normal tissue stained with Hoechst dye (blue). Each paired symbols represents one mouse (n = 7), **p = 0.0078, one-tailed, Wilcoxon matched-paired signed rank test. c Relative F. nucleatum gDNA abundance (2−ΔCt) in breast tissue from tumor-free mice (No tumor, n = 3), and in tumor and matching normal tissue of 4T1 tumor-bearing mice (n = 5) all inoculated with F. nucleatum ATCC 23726. *p = 0.0358 Holm-corrected one-tailed Mann–Whitney test. *p = 0.0313, one-tailed, Wilcoxon matched-paired signed rank test (for paired normal adjacent-tumor samples). d Orthotropic AT3 C57BL/6 mouse mammary cancer model. When reaching 500 mm3, mice were inoculated with 5 × 107 F. nucleatum ATCC 23726 (726; blue), 5 × 107 Fap2 mutant K50 (MUT K50; red) or with 5 × 107 P. gingivalis (Pg; black). Twenty-four hours later, normal mammary and breast cancer tissue were harvested from each mice and bacteria quantified. e Bacterial abundance (CFU/g tissue), and relative bacterial gDNA abundance (2−ΔCt) in tumor and normal tissue of AT3 tumor-bearing mice inoculated with P. gingivalis (Pg, n = 9), K50 (n = 12), or F. nucleatum ATCC 23726 (726, n = 12). Each symbol represents one mouse. *p = 0.0156 one-tailed, Wilcoxon matched-paired signed rank test. ***p = 0.0006, **p = 0.001598. Holm-corrected one-tailed Mann–Whitney test (left panel). ****p < 0.0001. One-tailed, Wilcoxon matched-paired signed rank test. ****p < 0.0001 (726 – Pg). One-tailed Mann–Whitney test, Holm’s modification of Bonferroni correction (right panel). f Representative multiphoton microscopy images of tumor and of normal adjacent mammary samples harvested 24 h post-IV injection of AT3 cancer bearing mice with 5 × 107 FITC-labeled F. nucleatum ATCC 23726 or with PBS vehicle. Scale bar, 50 µm in (b), 10 µm in (f). Data shown are representative of three independent reproducible experiments. Source data are provided as a Source data file.CC BY · PubMed Central
Fig. 5 F. nucleatum ATCC 23726 accelerates tumor growth and progression of lung metastasis. a Experimental scheme: AT3 breast cancer cell line was injected to the mammary fat pad of 6–7-week-old C57BL/6 mice. When tumor size reached 500 mm3, PBS vehicle (V), 5 × 107 F. nucleatum ATCC 23726 only (726), 5 × 107 F. nucleatum ATCC 23726 with metronidazole (726+MTZ.), metronidazole only (MTZ.), or 5 × 107 Fap2-deficient F. nucleatum K50 were injected into the tail vein. On days 2–3 post inoculation, mice were injected twice a day with metronidazole (M) or with PBS vehicle (V). On days 4–7 post inoculation, mice were injected once a day with metronidazole or with PBS. Eight days after inoculation, mice were sacrificed, and tumor and lungs harvested. Breast cancer tissues were weighed, and lung metastases were counted. b Tumor weights normalized as the percentage compared with the average tumor weight in the PBS group (vehicle control) in each experiment (set as 100% tumor weight). Each symbol represents one mouse. Presented results are of three independent experiments. ****p = 3.48 × 10−5, **p = 0.002. Holm’s correction, one-tailed Mann–Whitney. Vehicle n = 21, MTZ. n = 17, K50 n = 7, 726 n = 19, 726+MTZ. n = 12. c Representative tumors post-harvest. d Representative image of lung metastases. Scale bar, 500 µm in the large image, 250 µm in the indicated inset. e Lung metastasis rank [number of metastases per lung area (pixel2)] calculated as percentage compared with the average metastasis rank in the vehicle control group of each experiment (set as 100% metastasis rank). Each symbol represents one mouse. Presented results are of three independent experiments. ****p = 4.08 × 10−5, *p = 0.0177, n.s.: non-significant, Holm’s correction, one-tailed Mann–Whitney. Vehicle n = 20, MTZ. n = 17, K50 n = 7, 726 n = 18, 726+met n = 12. f Images taken by fluorescence binocular of lung metastases in four mice implanted with GFP-expressing AT3 cells as described above. Two tumor-bearing mice were inoculated with F. nucleatum and two were treated by PBS vehicle. Scale bar, 1000 µm. Source data are provided as a Source data file.
Fig. 5 F. nucleatum ATCC 23726 accelerates tumor growth and progression of lung metastasis. a Experimental scheme: AT3 breast cancer cell line was injected to the mammary fat pad of 6–7-week-old C57BL/6 mice. When tumor size reached 500 mm3, PBS vehicle (V), 5 × 107 F. nucleatum ATCC 23726 only (726), 5 × 107 F. nucleatum ATCC 23726 with metronidazole (726+MTZ.), metronidazole only (MTZ.), or 5 × 107 Fap2-deficient F. nucleatum K50 were injected into the tail vein. On days 2–3 post inoculation, mice were injected twice a day with metronidazole (M) or with PBS vehicle (V). On days 4–7 post inoculation, mice were injected once a day with metronidazole or with PBS. Eight days after inoculation, mice were sacrificed, and tumor and lungs harvested. Breast cancer tissues were weighed, and lung metastases were counted. b Tumor weights normalized as the percentage compared with the average tumor weight in the PBS group (vehicle control) in each experiment (set as 100% tumor weight). Each symbol represents one mouse. Presented results are of three independent experiments. ****p = 3.48 × 10−5, **p = 0.002. Holm’s correction, one-tailed Mann–Whitney. Vehicle n = 21, MTZ. n = 17, K50 n = 7, 726 n = 19, 726+MTZ. n = 12. c Representative tumors post-harvest. d Representative image of lung metastases. Scale bar, 500 µm in the large image, 250 µm in the indicated inset. e Lung metastasis rank [number of metastases per lung area (pixel2)] calculated as percentage compared with the average metastasis rank in the vehicle control group of each experiment (set as 100% metastasis rank). Each symbol represents one mouse. Presented results are of three independent experiments. ****p = 4.08 × 10−5, *p = 0.0177, n.s.: non-significant, Holm’s correction, one-tailed Mann–Whitney. Vehicle n = 20, MTZ. n = 17, K50 n = 7, 726 n = 18, 726+met n = 12. f Images taken by fluorescence binocular of lung metastases in four mice implanted with GFP-expressing AT3 cells as described above. Two tumor-bearing mice were inoculated with F. nucleatum and two were treated by PBS vehicle. Scale bar, 1000 µm. Source data are provided as a Source data file.CC BY · PubMed Central
Fig. 6 AT3 mammary tumor acceleration by F. nucleatum is immune-mediated. a 1 × 106 AT3 cells were injected to the mammary fat pad of 6–7-week-old female C57BL/6 mice. When tumor volume reached 500 mm3, mice were IV injected with PBS vehicle or with 5 × 107 F. nucleatum ATCC 23726 (726). At day 8 post injection, mice were sacrificed, tumors were harvested subjected to flow cytometry and abundance of NK cells, CD4+ T cells and CD8+ T cells was determined. Boxplot whiskers represent extrema, box bounds represent upper and lower quartiles, and center-line represents the median value. n.s.: non-significant. **p = 0.00216, *p = 0.0152, two-tailed Mann–Whitney (each symbol represents the mean of two technical replicates, n = 6 per group). b 1 × 105 AT3 or GFP-expressing AT3 cells were injected to the mammary fat pad of 6–7-week-old female SCID-beige mice. When tumor volume reached 500 mm3, mice were IV injected with PBS vehicle or with 5 × 107 F. nucleatum ATCC 23726 (726). At day 8 post injection, mice were sacrificed, tumors were harvested and weighed in an analytic weigh. Boxplot whiskers represent extrema, box bounds represent upper and lower quartiles, and center-line represents the median value of two independent experiments. n.s.: non-significant. n = 8 per vehicle group and n = 10 per F. nucleatum-infected group. c Representative picture and densitometry analysis of gelatin zymography of conditioned medium prepared from mouse mammary tumor cell line AT3 or from the human breast cancer cell line MDA-MB-231 that were co-cultured or not, with F. nucleatum strains ATCC 25586 or ATCC 23726. Bars indicate mean ± SEM of six independent experiments. *p = 0.031 two-tailed paired Wilcoxon. Note that mouse MMP-9 is larger than that of human. Source data are provided as a Source data file.
Fig. 6 AT3 mammary tumor acceleration by F. nucleatum is immune-mediated. a 1 × 106 AT3 cells were injected to the mammary fat pad of 6–7-week-old female C57BL/6 mice. When tumor volume reached 500 mm3, mice were IV injected with PBS vehicle or with 5 × 107 F. nucleatum ATCC 23726 (726). At day 8 post injection, mice were sacrificed, tumors were harvested subjected to flow cytometry and abundance of NK cells, CD4+ T cells and CD8+ T cells was determined. Boxplot whiskers represent extrema, box bounds represent upper and lower quartiles, and center-line represents the median value. n.s.: non-significant. **p = 0.00216, *p = 0.0152, two-tailed Mann–Whitney (each symbol represents the mean of two technical replicates, n = 6 per group). b 1 × 105 AT3 or GFP-expressing AT3 cells were injected to the mammary fat pad of 6–7-week-old female SCID-beige mice. When tumor volume reached 500 mm3, mice were IV injected with PBS vehicle or with 5 × 107 F. nucleatum ATCC 23726 (726). At day 8 post injection, mice were sacrificed, tumors were harvested and weighed in an analytic weigh. Boxplot whiskers represent extrema, box bounds represent upper and lower quartiles, and center-line represents the median value of two independent experiments. n.s.: non-significant. n = 8 per vehicle group and n = 10 per F. nucleatum-infected group. c Representative picture and densitometry analysis of gelatin zymography of conditioned medium prepared from mouse mammary tumor cell line AT3 or from the human breast cancer cell line MDA-MB-231 that were co-cultured or not, with F. nucleatum strains ATCC 25586 or ATCC 23726. Bars indicate mean ± SEM of six independent experiments. *p = 0.031 two-tailed paired Wilcoxon. Note that mouse MMP-9 is larger than that of human. Source data are provided as a Source data file.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

2 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 55 references

Cited by

See all 716

Metadata

Authors
Parhi, L., Alon-Maimon, T., Sol, A., Nejman, D., Shhadeh, A., Fainsod-Levi, T., Yajuk, O., Isaacson, B., Abed, J., Maalouf, N., Nissan, A., Sandbank, J., Yehuda-Shnaidman, E., Ponath, F., Vogel, J., Mandelboim, O., Granot, Z., Straussman, R., & Bachrach, G.
Affiliations
  • Hebrew University of Jerusalem (IL)
  • Weizmann Institute of Science (IL)
  • Sheba Medical Center (IL)
  • Maccabi Healthcare Services (IL)
  • Helmholtz Institute for RNA-based Infection Research (DE)
  • University of Würzburg (DE)
Corresponding author
Bachrach, Gilad
Venue
Nature Communications
Published
2020-06-26
Volume
11
Issue
1
Pages
3259-3259
ISSN
2041-1723 (ISSN-L)
OpenAlex
W3037222958
Cited by
716
References
55
Citations by year
2026: 106 · 2025: 173 · 2024: 156 · 2023: 123 · 2022: 107 · 2021: 45 · 2020: 6
FWCI
36.62
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Communications (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • HZI (Helmholtz Centre for Infection Research) (submittedVersion, cc-by-nc-sa)
Funders
  • Israel Cancer Research Fund (Project grant)
  • Israel Science Foundation (Moked grant)
  • Israel Ministry of Science and Technology Personalized Medicine grant
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Bacterial Cancer Therapy
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
Keywords
Fusobacterium nucleatum, breast cancer, tumor colonization, tumor-associated bacteria, tumor growth, metastasis, tumor-infiltrating T cells, antibiotic therapy, oral microbiota
MeSH terms
Animals, Anti-Bacterial Agents, Bacterial Proteins, Breast Neoplasms, Disease Models, Animal, DNA, Bacterial, Female, Galactosamine, Galactose, Humans, Immunity, Lung Neoplasms, Mice, Inbred BALB C, Neoplasm Metastasis, Colony Count, Microbial, Genome, Bacterial, Fusobacterium nucleatum, Disease Progression, Cell Line, Tumor, Cell Proliferation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Breast cancer colonization by Fusobacterium nucleatum accelerates tumor growth and metastatic progression. https://app.cochat.ai/papers/10.1038/s41467-020-16967-2
The paper
Parhi, L., Alon-Maimon, T., Sol, A., Nejman, D., Shhadeh, A., Fainsod-Levi, T., Yajuk, O., Isaacson, B., Abed, J., Maalouf, N., Nissan, A., Sandbank, J., Yehuda-Shnaidman, E., Ponath, F., Vogel, J., Mandelboim, O., Granot, Z., Straussman, R., & Bachrach, G. (2020). Breast cancer colonization by Fusobacterium nucleatum accelerates tumor growth and metastatic progression. Nature Communications. https://doi.org/10.1038/s41467-020-16967-2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.